Swollen knee is a common syndrome mostly found in geriatric
adults. It occurs as a result of accumulation of excess fluid around the knee
joint. Causes for occurrence vary from trauma to accidents leading to injuries
such as torn ligaments, cartilage tear, and broken bones to some other
underlying disease, including rheumatoid arthritis, gout, and tumors. Knee
swelling leads to severe joint pains, which may require immediate medication.
In addition, the syndrome may lead to stiffness, thus making it difficult for
the patient to bend the knee properly.
Request for Sample Report@ https://www.alliedmarketresearch.com/request-sample/13717
COVID-19 Impact Analysis
Pharmaceutical and biotech companies together with
governments around the globe are working to address the COVID-19 outbreak, from
supporting the development of vaccines to planning for medicine supply chain
challenges. Currently, around 115 vaccine candidates and 155 molecules are in
the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine
have witnessed a dramatic surge in demand for the management of COVID-19. Such
high demand for these drugs has presented huge opportunities for manufacturers
of COVID-19 management drugs, as many developed countries are facing shortage
of these drugs. Thus, the pharmaceutical and biotechnology industries are
expected to witness a significant growth in the future, owing to the demand for
vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a
significant impact on the global swollen knee treatment market.
Global financial slowdown
coupled with complete shift of healthcare infrastructure toward battling
COVID-19 and related effects has resulted in delays in product launches and
cancellations with respect to clinical trials. This is bound to hamper market
growth of knee replacement market.
Growing shift
towards adoption of non-surgical healthcare mechanisms such as therapeutic
procedures, propaedeutic procedures coupled with growing awareness of the side
effects and complications associated with surgical replacements may hamper market
growth of knee replacement treatment mechanisms.
Key Market Players
- ·
Stryker Corporation
- ·
Zimmer Holdings
- ·
Smith & Nephew Plc.
- ·
DePuy Companies Inc.
- ·
Wright Medical Group Inc.
- ·
Biomet Inc.
- ·
Exactech
- ·
B. Braun Melsungen AG
- ·
Pfizer Inc.
- ·
Merck & Co.
0 Comments